Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are prescribed to patients with atrial fibrillation (AF) to reduce the risk of stroke. Prescribing the correct dose warrants careful consideration of the prevailing dose criteria that differ per NOAC. Electronic systems are useful to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, M. S., van Hulst, M., Campmans, Z., Tieleman, R. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639841/
https://www.ncbi.nlm.nih.gov/pubmed/30949972
http://dx.doi.org/10.1007/s12471-019-1267-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639841/
https://www.ncbi.nlm.nih.gov/pubmed/30949972
http://dx.doi.org/10.1007/s12471-019-1267-9

Ejemplares similares